PlainRecalls
FDA Drug Moderate Class II Terminated

Morphine Sulfate in 0.9% Sodium Chloride Injection, 100 mg per 100 mL (1 mg per mL), Rx only, SterRx, 141 Idaho Avenue, Plattsburgh, NY, 12903, NDC 70324-427-02.

Reported: January 5, 2022 Initiated: November 12, 2021 #D-0301-2022

Product Description

Morphine Sulfate in 0.9% Sodium Chloride Injection, 100 mg per 100 mL (1 mg per mL), Rx only, SterRx, 141 Idaho Avenue, Plattsburgh, NY, 12903, NDC 70324-427-02.

Reason for Recall

Lack of Assurance of Sterility

Details

Recalling Firm
SterRx, LLC
Units Affected
880 units
Distribution
U.S.A. Nationwide
Location
Plattsburgh, NY

Frequently Asked Questions

What product was recalled?
Morphine Sulfate in 0.9% Sodium Chloride Injection, 100 mg per 100 mL (1 mg per mL), Rx only, SterRx, 141 Idaho Avenue, Plattsburgh, NY, 12903, NDC 70324-427-02.. Recalled by SterRx, LLC. Units affected: 880 units.
Why was this product recalled?
Lack of Assurance of Sterility
Which agency issued this recall?
This recall was issued by the FDA Drug on January 5, 2022. Severity: Moderate. Recall number: D-0301-2022.